特朗普称孕期服用泰诺会增加胎儿患自闭症风险！各方这样看→

Core Viewpoint - The article discusses the recent statement by U.S. President Trump regarding the potential risk of acetaminophen (Tylenol) use during pregnancy and its association with autism, highlighting differing opinions from various health authorities and experts [3][5][7]. Group 1: Company Response - The manufacturer of Tylenol, Co., maintains that existing scientific evidence does not support the claim that acetaminophen use leads to autism, a view echoed by credible public health professionals [5]. - Co. emphasizes that the FDA has reviewed this issue for over a decade and continues to recommend acetaminophen use during pregnancy without changing the drug's labeling [6]. Group 2: Health Authority Perspectives - The World Health Organization (WHO) stated that while some observational studies suggest a potential link between prenatal exposure to acetaminophen and autism, the evidence is inconsistent, and multiple studies have not found such a connection [6]. - The European Medicines Agency has not found any evidence linking Tylenol use during pregnancy to autism, asserting that current recommendations regarding its use remain unchanged [7]. Group 3: Expert Opinions - Medical experts acknowledge that autism is a complex neurodevelopmental disorder with rising global prevalence, currently estimated at around 1%, with significant increases in reported cases over the past two decades [7][8]. - Experts advise that while acetaminophen may carry risks, it remains a primary choice for pain relief during pregnancy, and pregnant women should consult healthcare professionals before using any over-the-counter medications [8].